Bristol-Myers Squibb (BMS) operates in more than 60 countries around the globe. It is a major producer of therapies for cardiovascular, metabolic and infectious diseases, central nervous system and dermatological disorders, and cancer. It is also active in consumer medicines, orthopaedic devices, ostomy care, management, nutritional supplements, and infant formulas. The company has 41,000 employees and net sales of around $20.5bn in 2008. 
The medicines business consists of worldwide pharmaceuticals and consumer medicines. Areas of interest include anti-cancer therapies, heart disease, high blood pressure, stroke, and type II diabetes, HIV/Aids, depression, pain and anxiety.
History
The company was formed through a merger in 1989, which at that time was considered to be one of the largest in corporate history. In October 2001, BMS further strengthened its medicines business with the acquisition of DuPont Pharmaceuticals.
Today, it is a diversified worldwide health and personal care company whose core businesses are medicines, nutrition (Mead Johnson) and medical devices (ConvaTec).
Company movements
On 1 September 2009, Bristol-Myers Squibb completed the acquisition of Medarex for $2.4bn.
Medarex will become a wholly-owned subsidiary of Bristol-Myers Squibb.
Please go here for a full list of Bristol-Myers Squibb's products:
http://www.bms.com/products/data/index.html
Bristol Myers Squibb
Strategy & Financial Highlights
Bristol-Myers Squibb (BMS) will continue to execute its strategy for long term growth. Its strategy consists of increasing investments behind growth drivers, focusing the company's research and development programmes on products in the pharmaceutical pipeline in disease areas that address significant unmet medical needs, aligning sales and marketing emphasis on specialists and high value primary care prescribers, and implementing initiatives designed to achieve and maintain a more efficient cost base. ICIS also provides you with key financial data listed in table form.
More about Bristol Myers Squibb Strategy & Financial Highlights
News:
Get news on Bristol Myers Squibb plus the latest chemical news, information, data, market movements and analysis
in one place with ICIS news
Search:
Find details on other chemical companies and suppliers with
ICIS search
Newsletters:
ICIS offers a range of FREE e-newsletters to ensure that you don't miss out on the latest development and key market intelligence in your industry. If you want the latest news sent to your inbox, sign up for ICIS e-newsletters today.
Plants and projects:
Find out more about current and planned chemical plants and projects by subscribing to our comprehensive database